Qube Research & Technologies (QRT)
ZYME icon

Qube Research & Technologies (QRT)’s Zymeworks ZYME Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.5M Buy
593,590
+81,653
+16% +$2.07M 0.01% 1036
2026
Q1 		$12.8M Buy
511,937
+37,647
+8% +$891K 0.01% 1131
2025
Q4 		$12.5M Buy
474,290
+219,288
+86% +$4.78M 0.01% 1198
2025
Q3 		$4.36M Buy
255,002
+185,128
+265% +$2.65M ﹤0.01% 1840
2025
Q2 		$877K Buy
+69,874
New +$832K ﹤0.01% 2517
2025
Q1 		– Sell
-21,868
Closed -$320K – 3954
2024
Q4 		$320K Buy
+21,868
New +$306K ﹤0.01% 2689
2024
Q3 		– Sell
-101,398
Closed -$863K – 4251
2024
Q2 		$863K Sell
101,398
-58,901
-37% -$524K ﹤0.01% 1959
2024
Q1 		$1.69M Buy
160,299
+94,389
+143% +$1.05M ﹤0.01% 1851
2023
Q4 		$685K Sell
65,910
-29,358
-31% -$234K ﹤0.01% 2124
2023
Q3 		$604K Buy
95,268
+23,528
+33% +$174K ﹤0.01% 1941
2023
Q2 		$620K Sell
71,740
-99,574
-58% -$892K ﹤0.01% 1463
2023
Q1 		$1.55M Buy
+171,314
New +$1.49M 0.01% 1116
2022
Q4 		– Sell
-46,683
Closed -$287K – 3074
2022
Q3 		$287K Sell
46,683
-93,986
-67% -$567K ﹤0.01% 1643
2022
Q2 		$746K Buy
140,669
+17,313
+14% +$105K 0.01% 1227
2022
Q1 		$808K Buy
+123,356
New +$1.1M 0.01% 1287
2021
Q3 		– Sell
-11,080
Closed -$384K – 2867
2021
Q2 		$384K Sell
11,080
-8,579
-44% -$272K ﹤0.01% 1435
2021
Q1 		$621K Buy
19,659
+7,669
+64% +$312K 0.01% 1058
2020
Q4 		$567K Buy
+11,990
New +$557K 0.01% 1068
2020
Q3 		– Sell
-12,783
Closed -$461K – 2172
2020
Q2 		$461K Buy
+12,783
New +$471K 0.01% 1147
2020
Q1 		– Sell
-8,095
Closed -$368K – 1747
2019
Q4 		$368K Buy
+8,095
New +$294K 0.01% 1113

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ZYME Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Zymeworks (ZYME) stake by 16% in Q2 2026, buying an estimated $2.07M and bringing the position to 593,590 shares worth $15.5M. The position accounts for 0.01% of the portfolio, ranked #1036.

Qube Research & Technologies (QRT) first reported a position in ZYME in Q4 2019 and has held it in 20 quarters since. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Qube Research & Technologies (QRT) held 593,590 shares of Zymeworks worth $15.5M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 81,653 Zymeworks shares in Q2 2026, an estimated $2.07M.
  • Zymeworks made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1036 holding.
  • Qube Research & Technologies (QRT) first reported a position in Zymeworks in Q4 2019 and has held it in 20 quarters since.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.